Pharmaresearch Bio Co (XKRX:217950) Interest Expense : ₩-2,748 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pharmaresearch Bio Co's interest expense for the six months ended in Dec. 2023 was ₩ -2,748 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,748 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pharmaresearch Bio Co's Operating Income for the six months ended in Dec. 2023 was ₩ 6,223 Mil. Pharmaresearch Bio Co's Interest Expense for the six months ended in Dec. 2023 was ₩ -2,748 Mil. Pharmaresearch Bio Co's Interest Coverage for the quarter that ended in Dec. 2023 was 2.26. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmaresearch Bio Co Interest Expense Historical Data

The historical data trend for Pharmaresearch Bio Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Interest Expense Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-294.51

-358.72

-477.89

-2,820.20

-2,748.01

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Interest Expense	Get a 7-Day Free Trial			-294.51	-358.72	-477.89	-2,820.20	-2,748.01

Pharmaresearch Bio Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,748 Mil.

Pharmaresearch Bio Co (XKRX:217950) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmaresearch Bio Co's Interest Expense for the six months ended in Dec. 2023 was ₩-2,748 Mil. Its Operating Income for the six months ended in Dec. 2023 was ₩6,223 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was ₩490 Mil.

Pharmaresearch Bio Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	6223.276	/	-2748.01
	=	2.26

The higher the ratio, the stronger the company's financial strength is.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines